All documents tagged with this AR226 identifier.
| Title / Summary | Year | AR226 Docket | Hash ID | Pages |
|---|---|---|---|---|
| This document reports on a bacterial reverse mutation test conducted by DuPont Pharmaceuticals Company to evaluate the mutagenic potential of a substance, following U.S. EPA and OECD guidelines. | 1998 | AR226-3151 | mq6XrVRVKQpJ8dd6d335b5BKd | 25 |